Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

NCT00002556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

312

Enrollment

NIH

Sponsor class

Conditions

Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: vincristine sulfate
DRUG: carmustine
DRUG: melphalan
DRUG: cyclophosphamide
DRUG: prednisone
BIOLOGICAL: recombinant interferon alfa-2b
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)